GTx Announces Presentation of Ostarine and Acapodene Data at 2007 ASCO Annual Meeting
...2:00 to 6:00 p.m. -- Location: S Hall A2 About gtx GTx, headquartered in Memphis, Tenn., is a bioph...scle wasting and other serious medical conditions. gtx is developing ACAPODENE(R) (toremifene citrate), a...grade prostatic intraepithelial neoplasia, or PIN. gtx has licensed to Ipsen Limited exclusive rights in ...New Report Just Published: World Prostate Cancer Therapeutics Market Report
...pands HIFU Business in Europe by Entering into Spain II-82 Altana Divests Entire Stake in GPC Biotech II-83 Ipsen Enters into Partnership with gtx to Develop and Market Acapodene in Europe II-83 Egenix and Proteome Systems Collaborate to Develop Prostate Cancer Test Using Semen II-83 ...NVIDIA CUDA Technology Dramatically Advances the Pace of Scientific Research
...wer time is better. NVIDIA(R) GeForce(R) gtx 280-based system processes workload on the NVIDIA ...R) 780i SLI(TM)-based motherboard, NVIDIA gtx 280 GPU, Intel Core i7 965 CPU, 2GB DDR2 DRAM and ...wer time is better. NVIDIA(R) GeForce(R) gtx 280-based system processes workload on the NVIDIA ...Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes
...xt, Brussels: SOLB) UCB SA (Euronext, Brussels: UCB) Add ABRAXIS BIOSCIENCE INC NEW (NASDAQ: ABII ) ALTUS PHARMACEUTICALS INC (NASDAQ: ALTU ) gtx INC (NASDAQ: GTXI ) HOLOGIC INC (NASDAQ: HOLX ) PAR PHARMACEUTICAL COS INC (NYSE: PRX ) SUCAMPO PHARMACEUTICALS INC (NASDAQ: SCMP ) VALEANT PH...Midwest Investment Bank Piper Jaffray Resurges in New York City
...up 54 percent by the end of last week at $32.40 a share. This is a good sign for the biotech IPO market. The next two biotech IPOs up on the block are gtx (of Memphis, Tenn.) and Renovis (of Berkely, Calif.). Both are being taken out by Goldman Sachs and are looking to price between $13 and $15 a share w...